HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NDI Notification Guidance To Assist Puzzled Industry Could Emerge In 2009

This article was originally published in The Tan Sheet

Executive Summary

FDA tentatively aims this year to complete its guidance for new dietary ingredient notifications, which industry research shows are largely failing to pass the agency's scrutiny

You may also be interested in...



Hatch Flips Focus To NDI Guidance In McCain Steroid Bill Negotiations

In a bit of legislative jiu-jitsu, congressional dietary supplement champions have redirected Sen. John McCain from sponsoring a bill that would put new burdens on industry to backing a provision that requires FDA publish a guidance stakeholders have been pushing for

FDA To Fill Frankos' Shoes As Major Dietary Supplement Initiatives Pend

The successor to Vasilios "Bill" Frankos, FDA's director of Dietary Supplement Programs, will face a full plate of imminent and ongoing regulatory issues

Firms Share NDI Notification Tips And Experts Reveal Common Pitfalls

Early and frequent communication with FDA is key to earning an elusive FDA acceptance of a new dietary ingredient notification on the first try, an agriculture-tech firm executive says

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS136356

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel